|Day Low/High||40.24 / 40.73|
|52 Wk Low/High||36.00 / 45.79|
ENHANCED SYSTEM ALLOWS BETTER THREE-DIMENSIONAL IMAGES OF ARRHYTHMIAS IN THE HEART
INNOVATIVE SOLUTION DESIGNED FOR BLOOD AND PLASMA SCREENING MAINTAINS HIGHEST LEVELS OF ACCURACY WHILE SUBSTANTIALLY INCREASING PRODUCTIVITY
NEXT GENERATION OF HARMONIZED SYSTEMS, COMBINED WITH RECENTLY LAUNCHED ALINIQ PROFESSIONAL SERVICES, PROVIDE A UNIQUE SOLUTION TO HELP LABS AND HOSPITAL SYSTEMS ACHIEVE MEASURABLY BETTER HEALTHCARE PERFORMANCE
The largest investor conference for the health care industry kicks off on Monday in San Francisco.
The lawyer is the husband of Trump adviser Kellyanne Conway and works in corporate litigation.
ABT could be on course for 10% earnings growth this year, but will investors reward the company with a higher share price?
The S&P 500 may be ending 2016 with double-digit gains, but almost a third of the index's individual stocks are actually down this year. Here's how to avoid the laggards.
- CREATES A PREMIER MEDICAL DEVICE BUSINESS WITH LEADING POSITIONS IN CARDIOVASCULAR AND NEUROMODULATION MARKETS
Start 2017 on the right foot by selling your holdings in these five stocks.
Technical analysis shows investors interested in Boeing, Abbott Labs, Johnson & Johnson and Cardinal Health may increase returns by holding off on purchases.
The Federal Trade Commission says Abbott Laboratories can proceed with its proposed $25 billion acquisition of St. Jude Medical.
Abbott can now proceed with its $25 billion buy of St. Jude Medical.
Here is a look at some stocks that are poised for excellent dividend returns in 2017.
Here's a look at the 10 best dividend stocks to invest in for potential outperformance in 2017.
Typically, the best way to get sentiment to turn is to take the indexes down.
As the dominant player in the transcatheter aortic valve replacement market, Edwards doesn't 'need' large deals.
HIMX, GG, ABT, ILMN and ENT all were recently downgraded by TheStreet's Quant Ratings.
AT&T and Time Warner kicked off a hearing to defend their $84.5 billion merger. AT&T is no stranger to legal battles and anti-trust battles.
The medical device giant files a suit against Alere in the Delaware Court of Chancery hoping to walk away from their $7.9 billion merger agreement.
ALERE HAS LOST SIGNIFICANT VALUE DUE TO NUMEROUS DAMAGING BUSINESS DEVELOPMENTS THAT OCCURRED FOLLOWING THE MERGER AGREEMENT